Factors Facilitating and Hindering Development of a Medication Use Review Service in Eastern Europe and Iran-Cross-Sectional Exploratory Study.

Autor:	Tuula A; Institute of Pharmacy, University of Tartu, 50411 Tartu, Estonia., Volmer D; Institute of Pharmacy, University of Tartu, 50411 Tartu, Estonia., Jõhvik L; Hospital Pharmacy, Tartu University Hospital, 50406 Tartu, Estonia., Rutkovska I; Faculty of Pharmacy, Riga Stradins University, LV-1007 Riga, Latvia., Trečiokienė I; Pharmacy Center, Faculty of Medicine, Vilnius University, 01513 Vilnius, Lithuania., Merks P; Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, 01-938 Warsaw, Poland., Waszyk-Nowaczyk M; Department of Pharmaceutical Technology, Pharmacy Practice Division, Poznan University of Medical Sciences, 60-780 Poznan, Poland., Drozd M; Department of Humanities and Social Medicine, Medical University of Lublin, 20-093 Lublin, Poland., Tatarević A; Istrian Pharmacies, 52100 Pula, Croatia., Radovanlija M; Pharmacy Rajić, 34000 Požega, Croatia., Pacadi C; Mandis Pharm Community Pharmacies, 10000 Zagreb, Croatia., Meštrović A; Pharma Expert Consultancy and Education, 10040 Zagreb, Croatia., Viola R; Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary., Soós G; Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary., Rais C; Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania., Táerel AE; Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania., Kuzelova M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, 83232 Bratislava, Slovakia., Zare M; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran., Peymani P; Rady Faculty of Health Sciences, College of Pharmacy, University of Manitoba, Winnipeg, MB R3E 0T5, Canada., Oona M; Institute of Family Medicine and Public Health, University of Tartu, 50411 Tartu, Estonia., Scott M; Medicines Optimisation Innovation Centre, Antrim BT41 2RL, UK.
Jazyk:	angličtina
Zdroj:	Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2021 Sep 14; Vol. 9 (9). Date of Electronic Publication: 2021 Sep 14.
DOI:	10.3390/healthcare9091207
Abstrakt:	Polypharmacy is a common issue in patients with chronic diseases. Eastern-European countries and Iran are exploring possibilities for implementing the Medication Use Review (MUR) as a measure for optimizing medication use and ensuring medication safety in polypharmacy patients. The aim of this study was to gain insights into the development of the community pharmacy sector and map facilitators and barriers of MUR in Eastern Europe and Iran. The representatives of the framework countries received a questionnaire on community pharmacy sector indicators, current and future developments of pharmacies, and factors encouraging and hindering MUR. To answer the questionnaire, all representatives performed document analysis, literature review, and qualitative interviews with key stakeholders. The socio-ecological model was used for inductive thematic analysis of the identified factors. Current community pharmacist competencies in framework countries were more related to traditional pharmacy services. Main facilitators of MUR were increase in polypharmacy and pharmaceutical waste, and access to patients' electronic list of medications by pharmacists. Main barriers included the service being unfamiliar, lack of funding and private consultation areas. Pharmacists in the framework countries are well-placed to provide MUR, however, the service needs more introduction and barriers mostly on organizational and public policy levels must be addressed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu